AUSTIN, Texas, April 02, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the promotion of John C. McKew, PhD to the position of Chief Operating Officer, effective April 1, 2020, in addition to his current role as Chief Scientific Officer. In his new role, Dr. McKew will spearhead the advancement of Lumos Pharma´s clinical development plan and will continue to be a key part of the business development team as the company looks for additional assets to add to its pipeline. `Dr. McKew has extensive experience in preclinical and clinical development of novel therapeutics across the private...
|
